Using machine learning approaches to predict response to neoadjuvant chemotherapy in patients with triple-negative breast cancer

被引：0
|
作者：
Fisher, Timothy Byron
Li, Hongxiao
Ts, Rekha
Krishnamurthy, Jayashree
Bhattarai, Shristi
Janssen, Emiel A. M.
Kong, Jun
Aneja, Ritu
机构：
来源：
CANCER RESEARCH | 2022年 / 82卷 / 04期
关键词：
D O I：
10.1158/1538-7445.SABCS21-P1-08-16
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P1-08-16
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Bevacizumab in Neoadjuvant Chemotherapy Increases the Pathological Complete Response Rate in Patients With Triple-Negative Breast Cancer
    Barton, Mary Kay
    CA-A CANCER JOURNAL FOR CLINICIANS, 2014, 64 (03) : 155 - 156
  • [32] Collagen Density Is Associated With Pathological Complete Response to Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer Patients
    Li, Fengling
    Wei, Yani
    Li, Li
    Chen, Fei
    Bao, Chunjuan
    Bu, Hong
    Zhang, Zhang
    JOURNAL OF SURGICAL ONCOLOGY, 2024,
  • [33] An immunological signature to predict outcome in patients with triple-negative breast cancer with residual disease after neoadjuvant chemotherapy
    Blaye, C.
    Darbo, E.
    Debled, M.
    Brouste, V.
    Velasco, V.
    Pinard, C.
    Pellegrin, I.
    Tarricone, A.
    Arnedos, M.
    Commeny, J.
    Bonnefoi, H.
    Larmonier, C.
    Macgrogan, G.
    ANNALS OF ONCOLOGY, 2022, 33 : S127 - S127
  • [34] An immunological signature to predict outcome in patients with triple-negative breast cancer with residual disease after neoadjuvant chemotherapy
    Blaye, C.
    Darbo, E.
    Debled, M.
    Brouste, V
    Velasco, V.
    Pinard, C.
    Larmonier, N.
    Pellegrin, I
    Tarricone, A.
    Arnedos, M.
    Commeny, J.
    Bonnefoi, H.
    Larmonier, C.
    MacGrogan, G.
    ESMO OPEN, 2022, 7 (04)
  • [35] Is the benefit of using adjuvant capecitabine in patients with residual triple-negative breast cancer related to pathological response to neoadjuvant chemotherapy?
    Dulgar, Ozgecan
    Oven, Basak Bala
    Atci, Muhammed Mustafa
    Arikan, Rukiye
    Ay, Seval
    Ayhan, Murat
    Selvi, Oguzhan
    Ozyukseler, Deniz Tataroglu
    Bayram, Ertugrul
    Ozcan, Erkan
    Yasin, Ayse Irem
    Gumus, Mahmut
    EXPERT REVIEW OF ANTICANCER THERAPY, 2022, 22 (07) : 773 - 780
  • [36] Pathologic Response After Neoadjuvant Chemotherapy Predicts Locoregional Control in Patients With Triple-Negative Breast Cancer
    Gillespie, E.
    Chen, V. E.
    Murphy, J.
    Yashar, C. M.
    Lu, S. M.
    Einck, J. P.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S241 - S241
  • [37] Androgen Receptor Status and Prediction of Neoadjuvant Chemotherapy Response in Triple-Negative Breast Cancer
    Stoos, Catherine
    Huggins-Puhalla, Shannon
    Dabbs, David
    Bhargava, Rohit
    MODERN PATHOLOGY, 2016, 29 : 74A - 74A
  • [38] Androgen Receptor Status and Prediction of Neoadjuvant Chemotherapy Response in Triple-Negative Breast Cancer
    Stoos, Catherine
    Huggins-Puhalla, Shannon
    Dabbs, David
    Bhargava, Rohit
    LABORATORY INVESTIGATION, 2016, 96 : 74A - 74A
  • [39] Transcriptome Meta-Analysis of Triple-Negative Breast Cancer Response to Neoadjuvant Chemotherapy
    Zhang, Wei
    Li, Emma
    Wang, Lily
    Lehmann, Brian D. D.
    Chen, X. Steven
    CANCERS, 2023, 15 (08)
  • [40] Triple-Negative Breast Cancer and Predictive Markers of Response to Neoadjuvant Chemotherapy: A Systematic Review
    van den Ende, Nadine S. S.
    Nguyen, Anh H. H.
    Jager, Agnes
    Kok, Marleen
    Debets, Reno
    van Deurzen, Carolien H. M.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (03)
12345